The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 27, 2016

Filed:

Sep. 10, 2012
Applicants:

Shawn Walsh, Bridgewater, NJ (US);

Alexander Pasternak, Princeton, NJ (US);

Brian Cato, Secaucus, NJ (US);

Paul E. Finke, Milltown, NJ (US);

Jessica Frie, Princeton, NJ (US);

Qinghong Fu, Plainsboro, NJ (US);

Dooseop Kim, Seoul, KR;

Barbara Pio, West Orange, NJ (US);

Aurash Shahripour, Rahway, NJ (US);

Zhi-cai Shi, Monmouth Junction, NJ (US);

Haifeng Tang, Metuchen, NJ (US);

Inventors:

Shawn Walsh, Bridgewater, NJ (US);

Alexander Pasternak, Princeton, NJ (US);

Brian Cato, Secaucus, NJ (US);

Paul E. Finke, Milltown, NJ (US);

Jessica Frie, Princeton, NJ (US);

Qinghong Fu, Plainsboro, NJ (US);

Dooseop Kim, Seoul, KR;

Barbara Pio, West Orange, NJ (US);

Aurash Shahripour, Rahway, NJ (US);

Zhi-Cai Shi, Monmouth Junction, NJ (US);

Haifeng Tang, Metuchen, NJ (US);

Assignee:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/14 (2006.01); C07D 401/10 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01); C07D 403/10 (2006.01); C07D 405/06 (2006.01); C07D 405/12 (2006.01); C07D 487/04 (2006.01); C07D 211/28 (2006.01); C07D 211/62 (2006.01); C07D 211/48 (2006.01); C07D 471/08 (2006.01);
U.S. Cl.
CPC ...
C07D 401/10 (2013.01); C07D 211/28 (2013.01); C07D 211/48 (2013.01); C07D 211/62 (2013.01); C07D 403/10 (2013.01); C07D 405/06 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 413/14 (2013.01); C07D 471/08 (2013.01); C07D 487/04 (2013.01);
Abstract

This invention relates to compounds having structural Formula I: and pharmaceutically acceptable salts thereof which are inhibitors of the Renal Outer Medullary Potassium (ROMK) channel (Kir1.1). The compounds of Formula I are useful as diuretics and natriuretics and therefore are useful for the therapy and prophylaxis of disorders resulting from excessive salt and water retention, including cardiovascular diseases such as hypertension and chronic and acute heart failure.


Find Patent Forward Citations

Loading…